TCT
LXRX icon

TIAA CREF Trust’s Lexicon Pharmaceuticals LXRX Stock Holding History

TIAA CREF Trust’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-114,993
Closed -$760K – 332
2015
Q1 		$760K Sell
114,993
-144,018
-56% -$983K 0.01% 261
2014
Q4 		$1.65M Buy
+259,011
New +$2.09M 0.02% 183

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

TIAA CREF Trust's LXRX Position: Q2 2015 in Review

TIAA CREF Trust sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2015, closing a stake of 114,993 shares — an estimated $760K sold.

TIAA CREF Trust first reported a position in LXRX in Q4 2014 and held it in 2 quarters. The position peaked at $1.65M in Q4 2014. 94 funds tracked by Wall St. Rank hold LXRX as of Q2 2015.

  • TIAA CREF Trust reported no remaining Lexicon Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • TIAA CREF Trust sold 114,993 Lexicon Pharmaceuticals shares in Q2 2015, an estimated $760K.
  • TIAA CREF Trust first reported a position in Lexicon Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • TIAA CREF Trust's Lexicon Pharmaceuticals position peaked at $1.65M in Q4 2014.
  • 94 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2015.

Based on TIAA CREF Trust's 13F filing for Q2 2015, filed 28 Jul 2015.